NCT01835899View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of Multiple Rising Oral Doses of BI 1015550 Powder for Oral Solution

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Healthy
Interventions
DRUG

Placebo

Placebo to BI 1015550

DRUG

BI 1015550

medium dose 1 powder for oral solution

DRUG

BI 1015550

medium dose 2 powder for oral solution

DRUG

BI1015550

low dose 2 powder for oral solution

DRUG

BI 1015550

low dose 1 powder for oral solution

Trial Locations (1)

Unknown

1305.2.1 Boehringer Ingelheim Investigational Site, Mannheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT01835899 - Safety, Tolerability and Pharmacokinetics of Multiple Rising Oral Doses of BI 1015550 Powder for Oral Solution | Biotech Hunter | Biotech Hunter